Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, plus Rituxan (R/CHOP): Randomized, Cross-Over Study
Publication
, Conference
Vadhan-Raj, S; Spasojevic, I; Zhou, X; Romaguera, JE; Fanale, MA; Fayad, LE; Fowler, NH; Huen, A; Hagemeister, FB; Rodriguez, MA; Neelapu, SS ...
Published in: BLOOD
November 18, 2011
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
702 / 702
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Vadhan-Raj, S., Spasojevic, I., Zhou, X., Romaguera, J. E., Fanale, M. A., Fayad, L. E., … Kwak, L. W. (2011). Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, plus Rituxan (R/CHOP): Randomized, Cross-Over Study. In BLOOD (Vol. 118, pp. 702–702). San Diego, CA: AMER SOC HEMATOLOGY.
Vadhan-Raj, Saroj, Ivan Spasojevic, Xiao Zhou, Jorge E. Romaguera, Michelle A. Fanale, Luis E. Fayad, Nathan H. Fowler, et al. “Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, plus Rituxan (R/CHOP): Randomized, Cross-Over Study.” In BLOOD, 118:702–702. AMER SOC HEMATOLOGY, 2011.
Vadhan-Raj S, Spasojevic I, Zhou X, Romaguera JE, Fanale MA, Fayad LE, et al. Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, plus Rituxan (R/CHOP): Randomized, Cross-Over Study. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 702–702.
Vadhan-Raj, Saroj, et al. “Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, plus Rituxan (R/CHOP): Randomized, Cross-Over Study.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 702–702.
Vadhan-Raj S, Spasojevic I, Zhou X, Romaguera JE, Fanale MA, Fayad LE, Fowler NH, Huen A, Hagemeister FB, Rodriguez MA, Neelapu SS, Samaniego F, Younes A, Kwak LW. Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, plus Rituxan (R/CHOP): Randomized, Cross-Over Study. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 702–702.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
702 / 702
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology